(Q43832376)

27 November 2017

title

Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys (English)

1 reference

27 November 2017

Ou LY

1

1 reference

27 November 2017

Tang XC

series ordinal

2

1 reference

27 November 2017

Cai JX

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

European Journal of Pharmacology

27 November 2017

published in

1 reference

27 November 2017

volume

433

1 reference

27 November 2017

issue

2-3

1 reference

27 November 2017

page(s)

151-156

1 reference

The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Catecholamine mechanisms in age-related cognitive decline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Catecholamine modulation of prefrontal cortical cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: Indirect effects of yohimbine versus direct effects of clonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Huperzine A, a novel promising acetylcholinesterase inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Selective loss of central cholinergic neurons in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Increased activity of surviving locus ceruleus neurons in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Differential effects of d- and l-propranolol on dopamine turnover stimulated by oxotremorine in striatal and mesolimbic areas of rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Second generation cholinesterase inhibitors: effect of (L)-huperzine-A on cortical biogenic amines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901500-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01500-X

1 reference

27 November 2017

1 reference